Skip to main content

Cancer Immunology, Immunotherapy

Ausgabe 6/2024

Inhalt (20 Artikel)

CD200 is overexpressed in the pancreatic tumor microenvironment and predictive of overall survival

  • Open Access
  • Research

Jessica Wedig, Shrina Jasani, Debasmita Mukherjee, Hannah Lathrop, Priya Matreja, Timothy Pfau, Liliana D’Alesio, Abigail Guenther, Lexie Fenn, Morgan Kaiser, Molly A. Torok, Jake McGue, Gina M. Sizemore, Anne M. Noonan, Mary E. Dillhoff, Bradley W. Blaser, Timothy L. Frankel, Stacey Culp, Phil A. Hart, Zobeida Cruz-Monserrate, Thomas A. Mace

Integrating bulk and single-cell sequencing data to construct a Scissor+ dendritic cells prognostic model for predicting prognosis and immune responses in ESCC

  • Open Access
  • Research

Maosheng Cheng, Jianqi Xiong, Qianwen Liu, Caihua Zhang, Kang Li, Xinyuan Wang, Shuang Chen

Incorporating IL7 receptor alpha signaling in the endodomain of B7H3-targeting chimeric antigen receptor T cells mediates antitumor activity in glioblastoma

  • Open Access
  • Research

Nithidol Sakunrangsit, Nattarika Khuisangeam, Thananya Inthanachai, Varalee Yodsurang, Pasrawin Taechawattananant, Koramit Suppipat, Supannikar Tawinwung

T-cell subsets and cytokines are indicative of neoadjuvant chemoimmunotherapy responses in NSCLC

  • Open Access
  • Research

Ling Yi, Ziwei Xu, Tianyu Ma, Chong Wang, Panjian Wei, Bo Xiao, Hongtao Zhang, Nanying Che, Zhidong Liu, Yi Han

Comparative performance of scFv-based anti-BCMA CAR formats for improved T cell therapy in multiple myeloma

  • Open Access
  • Research

Sophia Stock, Luisa Fertig, Adrian Gottschlich, Janina Dörr, Florian Märkl, Lina Majed, Vivien D. Menkhoff, Ruth Grünmeier, Kai Rejeski, David M. Cordas dos Santos, Sebastian Theurich, Michael von Bergwelt-Baildon, Stefan Endres, Marion Subklewe, Sebastian Kobold

Expansion of tumor-infiltrating lymphocytes from head and neck squamous cell carcinoma to assess the potential of adoptive cell therapy

  • Open Access
  • Research

Sangjoon Choi, Mofazzal Hossain, Hyun Lee, Jina Baek, Hye Seon Park, Chae-Lyul Lim, DoYeon Han, Taehyun Park, Jong Hyeok Kim, Gyungyub Gong, Mi-Na Kweon, Hee Jin Lee

TLR5 agonist in combination with anti-PD-1 treatment enhances anti-tumor effect through M1/M2 macrophage polarization shift and CD8+ T cell priming

  • Open Access
  • Research

Junseok Lee, Keon-Il Im, Sojin Gil, Hyemin Na, Gi-June Min, Nayoun Kim, Seok-Goo Cho

Intratumor injection of BCG Ag85A high-affinity peptides enhanced anti-tumor efficacy in PPD-positive melanoma

  • Open Access
  • Research

Lanqun Qin, Guiying Zhang, Yirong Wu, Yueling Yang, Zhengyun Zou

Associations of granulocyte colony-stimulating factor with toxicities and efficacy of chimeric antigen receptor T-cell therapy in relapsed or refractory B-cell acute lymphoblastic leukemia

  • Open Access
  • Research

Sha Ma, Ying Wang, Kunming Qi, Wenyi Lu, Yuekun Qi, Jiang Cao, Mingshan Niu, Depeng Li, Wei Sang, Zhiling Yan, Feng Zhu, Hai Cheng, Zhenyu Li, Mingfeng Zhao, Kailin Xu

Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study

  • Open Access
  • Research

Francesco Massari, Matteo Santoni, Hideki Takeshita, Yohei Okada, Jose Carlos Tapia, Umberto Basso, Marco Maruzzo, Sarah Scagliarini, Thomas Büttner, Giuseppe Fornarini, Zin W. Myint, Luca Galli, Vinicius Carrera Souza, Renate Pichler, Ugo De Giorgi, Nathalia Gandur, Elaine T. Lam, Danielle Gilbert, Lazar Popovic, Enrique Grande, Giulia Mammone, Rossana Berardi, Simon J. Crabb, Robert Kemp, Javier Molina-Cerrillo, Marcelo Freitas, Murilo Luz, Roberto Iacovelli, Fabio Calabrò, Deniz Tural, Francesco Atzori, Zsófia Küronya, Rita Chiari, Saul Campos, Orazio Caffo, André P. Fay, Jakub Kucharz, Paolo Andrea Zucali, José Augusto Rinck, Annalisa Zeppellini, Diogo Assed Bastos, Gaetano Aurilio, Augusto Mota, Karine Trindade, Cinzia Ortega, Juan Pablo Sade, Mimma Rizzo, Ondřej Fiala, Nuno Vau, Patrizia Giannatempo, Allan Barillas, Fernando Sabino M. Monteiro, Breno Dauster, Alessia Mennitto, Lucas Nogueira, Roni de Carvalho Fernandes, Emmanuel Seront, Luís Garcia Aceituno, Francesco Grillone, Hernan Javier Cutuli, Mauricio Fernandez, Maria Bassanelli, Ray Manneh Kopp, Giandomenico Roviello, Halima Abahssain, Giuseppe Procopio, Michele Milella, Jindrich Kopecky, Angelo Martignetti, Carlo Messina, Manuel Caitano, Eva Inman, Ravindran Kanesvaran, Daniel Herchhorn, Daniele Santini, Aristotelis Bamias, Renato Bisonni, Alessandra Mosca, Franco Morelli, Fernando Maluf, Andrey Soares, Fernando Nunes, Alvaro Pinto, Anca Zgura, Lorena Incorvaia, Jawaher Ansari, Ignacio Ortego Zabalza, Johannes Landmesser, Alessandro Rizzo, Veronica Mollica, Andrea Marchetti, Matteo Rosellini, Giulia Sorgentoni, Nicola Battelli, Sebastiano Buti, Camillo Porta, Joaquim Bellmunt

A phase I trial of autologous RAK cell immunotherapy in metastatic renal cell carcinoma

  • Open Access
  • Research

Jing Xu, Wen Zhang, Jinlian Tong, Caixia Liu, Qiaohui Zhang, Liren Cao, Jiangyong Yu, Aiping Zhou, Jie Ma

A2AR-mediated CXCL5 upregulation on macrophages promotes NSCLC progression via NETosis

  • Open Access
  • Research

Qingyang Lei, Shanshan Zhen, Lei Zhang, Qitai Zhao, Li Yang, Yi Zhang

Synergistic immunomodulatory effect of synbiotics pre- and postoperative resection of pancreatic ductal adenocarcinoma: a randomized controlled study

  • Open Access
  • Research

Sara Maher, Hesham A. Elmeligy, Tarek Aboushousha, Noha Said Helal, Yousra Ossama, Mahmoud Rady, Ahmed Mohamed A. Hassan, Manal Kamel

Interleukin 33 supports squamous cell carcinoma growth via a dual effect on tumour proliferation, migration and invasion, and T cell activation

  • Open Access
  • Research

Graziela Perri, Vanessa Garcia Vilas Boas, Maria Renata Sales Nogueira, Edgard José Franco Mello Júnior, Ana Lucia Coelho, Edwin M. Posadas, Cory Hogaboam, Karen A Cavassani, Ana Paula Campanelli

Clonal expansion of shared T cell receptors reveals the existence of immune commonality among different lesions of synchronous multiple primary lung cancer

  • Open Access
  • Research

Yadong Wang, Zhicheng Huang, Bowen Li, Jianchao Xue, Chao Guo, Zhongxing Bing, Zhibo Zheng, Yang Song, Yuan Xu, Guanghua Huang, Haochen Li, Xiaoqing Yu, Yankai Xia, Ruirui Li, Xiaoyan Si, Li Zhang, Ji Li, Lan Song, Yuanyuan Xiong, Dejian Gu, Mengmeng Song, Zhipeng Zhou, Rongrong Chen, Zhe Feng, Zhixin Bie, Xiaoguang Li, Huaxia Yang, Shanqing Li, Naixin Liang

New genetic insights into immunotherapy outcomes in gastric cancer via single-cell RNA sequencing and random forest model

  • Open Access
  • Research

Dajun Yu, Jie Yang, BinBin Wang, Zhixiang Li, Kai Wang, Jing Li, Chao Zhu

Neutrophil-activating secretome characterizes palbociclib-induced senescence of breast cancer cells

  • Open Access
  • Research

Gabriele Favaretto, Marianna Nicoletta Rossi, Lorenzo Cuollo, Mattia Laffranchi, Manuela Cervelli, Alessandra Soriani, Silvano Sozzani, Angela Santoni, Fabrizio Antonangeli

Expression patterns of novel immunotherapy targets in intermediate- and high-grade lung neuroendocrine neoplasms

  • Open Access
  • Research

Bence Ferencz, Klára Török, Orsolya Pipek, János Fillinger, Kristóf Csende, András Lantos, Radoslava Černeková, Marcel Mitták, Jozef Škarda, Patricie Delongová, Evelyn Megyesfalvi, Karin Schelch, Christian Lang, Anna Solta, Kristiina Boettiger, Luka Brcic, Jörg Lindenmann, Ferenc Rényi-Vámos, Clemens Aigner, Judit Berta, Zsolt Megyesfalvi, Balázs Döme

Neu im Fachgebiet Onkologie

Dänische Zwillingsstudie deutet auf erhöhtes Krebsrisiko bei Tätowierten hin

Haben Tattoo-Träger und -Trägerinnen ein erhöhtes Risiko, an Hautkrebs oder einem Lymphom zu erkranken? Die Ergebnisse einer Zwillingsstudie aus Dänemark scheinen dafür zu sprechen. Die Forschungsgruppe rät vorerst zur Zurückhaltung beim Tätowieren.

Weniger PSA-Screening, mehr fortgeschrittene Tumoren

Eine Empfehlung gegen das Prostatakrebs-Screening, die mehrere Jahre in den Leitlinien des Royal Australasian College of General Practitioners gegeben wurde, hat sich nicht nur auf die Rate von PSA-Tests negativ ausgewirkt.

Schützt kutane Autoimmunität vor Hauttumoren?

Schwedische Registerdaten deuten auf ein geringeres Risiko für bestimmte Hauttumoren bei Personen mit Vitiligo oder autoimmuner Alopezie. Wie es dazu kommt, ist dagegen unklar.

Muss man wirklich auch die letzte Krebszelle eliminieren?

Genauere Prognoseabschätzung, bessere Therapiesteuerung und eine schnellere Entwicklung innovativer Behandlungsansätze – der Messung der minimalen Resterkrankung (MRD) wird ein enormes Potenzial attestiert. Eine Übersichtsarbeit unterstreicht jetzt aber: Es gibt noch blinde Flecken.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.